Annual Drug Patent Expirations for TARCEVA
Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TARCEVA.
The generic ingredient in TARCEVA is erlotinib hydrochloride. One supplier is listed for this compound. Additional details are available on the erlotinib hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
